Driving Innovation in TIL Therapy with a Pipeline Update from KSQ Therapeutics
Time: 9:10 am
day: Conference Day One AM
Details:
- Showcasing recent clinical data on the efficacy and safety of KSQ Therapeutics’ engineered TIL therapies across multiple cancer types
- Exploring how gene-editing strategies are improving TIL function and persistence, with implications for more durable and effective patient outcomes
